SME
IPO ·
NSE SME
KRM Ayurveda Ltd
Listed
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
Issue details
Price band
₹128 – ₹135
Face value
₹10
Lot size
1,000 shares
Minimum investment
₹2,70,000
Issue size
₹77.49 Cr
Fresh issue
₹69.74 Cr
Offer for sale
—
Issue type
Book Built
Exchange
NSE SME
Key dates
Opens
21 Jan 2026
Closes
23 Jan 2026
UPI mandate cut-off
5:00 PM on 23 Jan 2026
Allotment
27 Jan 2026
Refunds
28 Jan 2026
Shares in demat
28 Jan 2026
Listing
29 Jan 2026
Subscription and listing
Subscription
52.19x
Listing price
₹172.10
Registrar
Skyline Financial Services Pvt Ltd
Lead manager
NEXGEN Financial Solutions
Subscription by category
Total
52.19x
Total applications
65,297
Anchor investors
Amount raised
₹20.82 Cr
Bid date
20 Jan 2026
50% lock-in ends
21 Feb 2026
Rest lock-in ends
22 Apr 2026
Listing day
Issue price
₹135
Open
₹172.10
High
₹180.70
Low
₹165.15
Day close
₹180.70
Listing gain at open
+27.48%
Issue structure
Shares reserved per category and share of the total issue
QIB Shares Offered
25,74,000
44.84%
Anchor Investor Shares Offered
15,42,000
26.86%
QIB (Ex. Anchor) Shares Offered
10,32,000
17.98%
NII Shares Offered
7,80,000
13.59%
bNII > ₹10L
5,19,000
9.04%
sNII < ₹10L
2,61,000
4.55%
Retail Shares Offered
18,12,000
31.57%
Market Maker Shares Offered
5,74,000
10.00%
Total Shares Offered
57,40,000
100.00%
Finaccle’s quick read
Apply
FY25 income up 14%, PAT up 255%, ROE 21.84%, D/E 0.69, post-issue P/E 23.73x.
A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.
About the company
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities: Beds, including general wards and premium rooms. Panchakarma treatment units.
Founded
Promoters
Promoter holding
Financial performance
Period
PAT
ROE
21.84%
ROCE
21.84%
Debt / equity
0.69
PAT margin
16.83%
P/E post issue
23.73
Market cap
₹287.02 Cr
Use of IPO money
Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
₹13.67 Cr
Purchase of CRM Software and Hardware Infrastructure
₹1.42 Cr
Human Resources
₹5.44 Cr
Repayment/Prepayment of loan
₹12.50 Cr
Working Capital Requirement
₹22.90 Cr
General Corporate Purposes
₹10.00 Cr
Issue Expenses
₹11.57 Cr
Strengths
✓
: Skilled Ayurvedic physicians and certified therapists ensuring treatment quality
✓
Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy
✓
PAT up 255% in FY25 to ₹12.10 Cr
✓
PAT margin of 16.83%
✓
ROE of 21.84% and ROCE of 21.84%
Risks to watch
!
SME platform: large lot size and thinner trading liquidity
Planning to take your own company public?
Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.
Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.
Last updated:
Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.